Showing results (1-10 of 78) with videos related to
Sort By:
Pageof 8
Expert Review of Vaccines|July 27, 2013
Clinical vaccine development for H5N1 influenzaChristopher H Clegg, Joseph A Rininger, Susan L BaldwinProceedings of the National Academy of Sciences of the United States of America|October 10, 2012
Adjuvant solution for pandemic influenza vaccine productionChristopher H Clegg, Richard Roque, Neal Van Hoeven, et al.Plos One|February 20, 2014
GLA-AF, an emulsion-free vaccine adjuvant for pandemic influenzaChristopher H Clegg, Richard Roque, Lucy A Perrone, et al.Current Opinion in Chemical Biology|July 23, 2002
Staking out novelty on the genomic frontierKerry E Quinn-Senger, Ravi Ramachandran, Joseph A Rininger, et al.Plos One|May 27, 2021
Epitope-targeting platform for broadly protective influenza vaccinesDavid F Zeigler, Emily Gage, Christopher H CleggVaccine|February 18, 2019
Optimization of a multivalent peptide vaccine for nicotine addictionDavid F Zeigler, Richard Roque, Christopher H CleggPlos One|June 2, 2017
Construction of an enantiopure bivalent nicotine vaccine using synthetic peptidesDavid F Zeigler, Richard Roque, Christopher H CleggPlos One|December 11, 2014
Novel Anti-Nicotine Vaccine Using a Trimeric Coiled-Coil Hapten CarrierKeith D Miller, Richard Roque, Christopher H CleggImmunology|May 19, 2004
Interleukin-21 is a T-helper cytokine that regulates humoral immunity and cell-mediated anti-tumour responsesPallavur V Sivakumar, Donald C Foster, Christopher H CleggPageof 8